Coacervate-mediated novel pancreatic cancer drug Aleuria Aurantia lectin delivery for augmented anticancer therapy

BACKGROUND: Pancreatic cancer, one of the cancers with the highest mortality rate, has very limited clinical treatment. Cancer cells express abnormal glycans on the surface, and some lectins with a high affinity for the glycans induce apoptosis in cancer. In this study, the efficacy of Aleuria Auran...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sungjun, Choi, Yunyoung, Kim, Kyobum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308356/
https://www.ncbi.nlm.nih.gov/pubmed/35869562
http://dx.doi.org/10.1186/s40824-022-00282-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308356/
https://www.ncbi.nlm.nih.gov/pubmed/35869562
http://dx.doi.org/10.1186/s40824-022-00282-6

Ejemplares similares